Ushbu ishga iqtibos qilgan ishlar

1 ta ish

Ish: Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

1. Outsmarting Antigen Escape: Next‐Generation <scp>CAR</scp> T Cell Engineering Strategies for Durable Remissions in Hematologic Malignancies

   Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Islam Alfreahat, Nurillo Bobokulov +5

   Maqola20260 iqtibos

   ABIABI:AkademIndex/2026.article.037558